Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05015751 · ClinicalTrials.gov registry record
Assessment of CSF Shunt Flow With Thermal Measurements A
A clinical trial, sponsored by Rhaeos.
- Completed
- Registry status
- 44
- Enrollment target
NCT05015751: Completed study, sponsored by Rhaeos.
NCT05015751 is a clinical trial that has completed, run by Rhaeos. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05015751 has completed, sponsored by Rhaeos.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
Primary Outcome
Study device sensitivity is calculated as TP / (TP + FN), where TP = true positive and FN = false negative.
Interventions
- DEVICE Thermal Anisotropy Measurement Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-08-25 |
| Est. Completion | 2022-07-13 |
What the finished NCT05015751 record still lists
NCT05015751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.
NCT05015751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05015751 about?
NCT05015751 is a clinical study titled "Assessment of CSF Shunt Flow With Thermal Measurements A". This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
What is the current status of trial NCT05015751?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2021-08-25. Estimated completion is 2022-07-13.
What interventions are being tested in trial NCT05015751?
The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT05015751?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI